1.42

7.79% -0.12

Precigen Inc (PGEN)

Overview News Price History Option Chain Financials Discussions Forecast

Precigen Inc stock is traded at $1.42, with a volume of 2.34M. It is down -7.79% in the last 24 hours and down -2.07% over the past month. Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Previous Close:

$1.54

Open:

$1.55

24h Volume:

2.34M

Relative Volume:

1.51

Market Cap:

$454.58M

Revenue:

$6.23M

Net Income/Loss:

$-95.90M

P/E Ratio:

-3.641

EPS:

-0.39

Net Cash Flow:

$-68.47M

1W Performance:

-7.79%

1M Performance:

-2.07%

6M Performance:

+105.74%

1Y Performance:

-12.88%

1-Day Range:

$1.415

$1.56

1-Week Range:

$1.415

$1.593

52-Week Range:

$0.6513

$2.17

Precigen Inc Stock (PGEN) Company Profile

Name

Precigen Inc

Sector

Healthcare (1172)

Industry

Biotechnology (662)

Phone

301-556-9900

Address

20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD

Employee

Twitter

@precigen

Next Earnings Date

2025-03-19

Latest SEC Filings

PGEN's Discussions on Twitter

Compare PGEN with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PGEN Precigen Inc	1.42	454.58M	6.23M	-95.90M	-68.47M	-0.39
VRTX Vertex Pharmaceuticals Inc	441.99	115.95B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	508.86	56.52B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	308.71	39.44B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	540.71	35.14B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	254.09	28.51B	3.81B	-644.79M	-669.77M	-6.24

Precigen Inc Stock (PGEN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-22-24	Downgrade	JP Morgan	Neutral → Underweight
May-23-23	Initiated	JP Morgan	Neutral
Nov-18-22	Initiated	Cantor Fitzgerald	Overweight
Feb-25-21	Initiated	Stifel	Buy
Feb-22-21	Initiated	Wells Fargo	Overweight
Feb-18-21	Initiated	B. Riley Securities	Buy
May-08-20	Initiated	H.C. Wainwright	Buy

View All

Precigen Inc Stock (PGEN) Latest News

Jun 16, 2025

High Growth Tech Stocks To Watch In The US June 2025 - simplywall.st

Jun 16, 2025

Jun 15, 2025

Bank of America Corp DE Has $232,000 Position in Precigen, Inc. (NASDAQ:PGEN) - Defense World

Jun 15, 2025

Jun 14, 2025

Precigen stock price target maintained at $6 by JMP on RRP therapy - Investing.com Nigeria

Jun 14, 2025

Jun 13, 2025

Precigen’s SWOT analysis: gene therapy firm’s stock poised for potential breakthrough - Investing.com Australia

Jun 13, 2025

Precigen (NASDAQ:PGEN) Given “Market Outperform” Rating at JMP Securities - Defense World

Jun 13, 2025

Jun 12, 2025

JMP Securities Reiterates PGEN with Market Outperform Rating | P - GuruFocus

Jun 12, 2025

JMP Securities Reiterates PGEN with Market Outperform Rating | PGEN Stock News - GuruFocus

Jun 12, 2025

Precigen, Inc.'s (NASDAQ:PGEN) market cap touched US$455m last week, benefiting both private equity firms who own 33% as well as institutions - Yahoo Finance

Jun 12, 2025

Cantor Fitzgerald Weighs in on Precigen FY2026 Earnings - Defense World

Jun 12, 2025

Jun 06, 2025

BNP Paribas Financial Markets Acquires New Position in Precigen, Inc. (NASDAQ:PGEN) - Defense World

Jun 06, 2025

Jun 04, 2025

ProShare Advisors LLC Buys 10,900 Shares of Precigen, Inc. (NASDAQ:PGEN) - Defense World

Jun 04, 2025

Jun 01, 2025

Top 5 Synthetic Biology Public Companies (June 2025) - Securities.io

Jun 01, 2025

May 31, 2025

Precigen, Inc. (NASDAQ:PGEN) Shares Acquired by Cetera Investment Advisers - Defense World

May 31, 2025

May 28, 2025

Precigen, Inc. (NASDAQ:PGEN) Shares Purchased by Northern Trust Corp - Defense World

May 28, 2025

May 26, 2025

D. E. Shaw & Co. Inc. Sells 792,731 Shares of Precigen, Inc. (NASDAQ:PGEN) - Defense World

May 26, 2025

May 24, 2025

Precigen (NASDAQ:PGEN) Downgraded to “Sell” Rating by Wall Street Zen - Defense World

May 24, 2025

May 20, 2025

Precigen, Inc. (NASDAQ:PGEN) Shares Sold by Price T Rowe Associates Inc. MD - Defense World

May 18, 2025

May 17, 2025

Cantor Fitzgerald Reiterates “Overweight” Rating for Precigen (NASDAQ:PGEN) - Defense World

May 17, 2025

May 16, 2025

Precigen First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

May 16, 2025

Stifel Financial Corp Acquires 58,657 Shares of Precigen, Inc. (NASDAQ:PGEN) - Defense World

May 16, 2025

May 15, 2025

Cantor Fitzgerald maintains Overweight on Precigen stock By Investing.com - Investing.com South Africa

May 15, 2025

Precigen (PGEN) Rating Reaffirmed as Overweight by Cantor Fitzge - GuruFocus

May 15, 2025

Precigen (PGEN) Rating Reaffirmed as Overweight by Cantor Fitzgerald | PGEN Stock News - GuruFocus

May 15, 2025

JMP maintains Precigen stock $6 target on PRGN-2012 optimism By Investing.com - Investing.com Nigeria

May 15, 2025

JMP maintains Precigen stock $6 target on PRGN-2012 optimism - Investing.com Australia

May 15, 2025

Cantor Fitzgerald maintains Overweight on Precigen stock - Investing.com

May 15, 2025

May 14, 2025

Precigen Reports First Quarter 2025 Financial Results and Business Updates - StreetInsider

May 14, 2025

Precigen Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 14, 2025